Boardroom Alpha
Boardroom Alpha
AMS · Additional Proxy Materials (DEFA14A) · Filed May 7, 2026

American Shared Hospital Services — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 7, 2026
Ticker
AMS
Accession
0001437749-26-015438
Boardroom Alpha · Filing insights

American Shared Hospital Services corrects 2024 audit-fee figures in proxy supplement; 2025 numbers updated.

About American Shared Hospital Services
Market cap
$9M
1Y TSR
−33.8%
3Y TSR
−15.4%
Board grade
B
Sector
Healthcare
CEO
Craig Kenji Tagawa
Last annual meeting: Jun 24, 2026 · View full American Shared Hospital Services profile →
asha20260506_defa14a.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No.         )

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

 

AMERICAN SHARED HOSPITAL SERVICES


(Name of Registrant as Specified In Its Charter)

 


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

AMERICAN SHARED HOSPITAL SERVICES

601 Montgomery Street, Suite 850

San Francisco, California 94111

 


 

SUPPLEMENT TO THE PROXY STATEMENT

FOR THE 2026 ANNUAL MEETING OF SHAREHOLDERS

June 24, 2026

 


 

On April 30, 2026, American Shared Hospital Services (the “Company”) filed its Definitive Proxy Statement (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) for the Company’s 2026 Annual Meeting of Shareholders to be held on June 24, 2026 (the “Annual Meeting”). This supplement (this “Supplement”) amends and supplements the Proxy Statement and is being filed solely to correct an administrative error on page 48 of the Proxy Statement in the table setting forth the fees billed by the Company’s independent registered public accounting firm, which inadvertently included fee information for fiscal year 2023 instead of fiscal year 2024. The corrected disclosure is set forth below.

 

This Supplement should be read in conjunction with the Proxy Statement and the other proxy materials previously distributed for the Annual Meeting. Except as specifically amended by this Supplement to make the correction set forth below, this Supplement does not otherwise modify or supplement the Proxy Statement in any manner, and all information set forth in the Proxy Statement remains unchanged and continues to apply.

 

This Supplement, dated May 6, 2026, is being filed with the SEC and made available to the Company’s shareholders on or about May 7, 2026. From and after the date of this Supplement, any references to the “Proxy Statement” are to the Proxy Statement as amended and supplemented by this Supplement.

 

Change to the Proxy Statement

 

The following table replaces the table set forth on page 48 of the Proxy Statement to correct the fees reflected for fiscal year 2024. Except for the corrections to such fees, no other changes have been made to the table or the accompanying footnotes.

 


 

The aggregate fees billed by Baker Tilly US, LLP and their respective affiliates (including Moss Adams LLP, as applicable) for professional services performed for 2025 and 2024 are as follows:

 

           

Audit-

                         
   

Audit Fees

   

Related

           

All Other

         
   

(1)

   

Fees (2)

   

Tax Fees (3)

   

Fees (4)

   

Total Fees

 

2025

  $ 915,075       --       --       --     $ 915,075  

2024

  $ 735,716     $ --     $ 16,247     $ --     $ 751,963  

 

(1)

Audit Fees: Consists of fees billed for professional services rendered in connection with the audit of our consolidated financial statements and review of interim condensed consolidated financial statements included in our quarterly reports and services normally provided in connection with statutory and regulatory filings or engagements.

 

(2)

Audit-Related Fees: Consists of fees generally related to accounting advice, review of SEC comment letters, and other compliance issues.

 

(3)

Tax Fees: Consists of tax compliance and preparation and other tax services.

 

(4)

All Other Fees: Consists of fees for all other services other than those reported above.

 

Important Voting Information

 

Proxy cards and voting instructions previously returned by shareholders and votes previously cast by shareholders will remain valid and will be used at the Annual Meeting unless changed or revoked.

 

If you have already voted, submitted voting instructions, or returned your proxy card, you do not need take any action unless you would like to change or revoke your prior vote, voting instructions, or proxy card. Please refer to the Proxy Statement for information regarding how to vote your shares and how to change or revoke your prior vote, voting instructions, or proxy card.

 

 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from American Shared Hospital Services (AMS)

Reference

Frequently asked questions

When did American Shared Hospital Services file this DEFA14A?
American Shared Hospital Services (AMS) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 7, 2026. The accession number assigned by EDGAR is 0001437749-26-015438.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
American Shared Hospital Services corrects 2024 audit-fee figures in proxy supplement; 2025 numbers updated. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find American Shared Hospital Services's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A American Shared Hospital Services has filed under CIK 744825, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer